| Offering Information |
| Expected Date | TBA |
| Proposed Exchange/Ticker |
Nasdaq: AGMX |
| Security Type |
Common Stock |
| Lead Underwriter |
JP Morgan |
| Days In Registration |
- |
| Date Filed |
25-Jul-2008 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
AutoGenomics, Inc designs, develops, manufactures and markets systems that assist in detecting the predisposition to and presence of disease, monitoring disease progression and/or guiding appropriate therapy. The company has developed one of the first automated microarray based multiplexing molecular diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious diseases, cancer and pharmacogenetics. Their principal executive offices are located at 2251 Rutherford Road, Carlsbad, California. It was incorporated in 1999. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
- |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
$86.3M |
| File Price Range |
- - - |
| File Mid Price |
- |
|
